Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • VRSK vs GSK✓SelectedUSD · GSKVRSK vs GSK performance historyLatest closeAs of+0.78%11/20
Stock and ETF performance explorer

VRSK vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+683.0%
GSK return
+185.9%
Excess return
+497.0%
Maximum drawdown
-50.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.8%-0.1%+0.9%+0.8%
7D-2.8%-5.3%+2.6%-1.1%
30D+5.1%-3.7%+8.7%+6.2%
3M+8.0%-7.3%+15.2%+10.3%
6M+19.1%-4.2%+23.3%+20.3%
YTD-8.9%+0.9%-9.8%-10.6%
1Y-8.0%+7.3%-15.3%-11.6%
3Y-13.7%+52.7%-66.4%-28.6%
5Y-9.0%+40.1%-49.1%-23.6%
10Y+156.3%+98.7%+57.6%+86.8%
All+683.0%+185.9%+497.0%+414.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling